Intracellular deposition, microtubule destabilization, and transport failure: An "early" pathogenic cascade leading to synaptic decline

Journal of Neuropathology and Experimental Neurology

Volumn 61, Issue 7, 2002, Pages 640-650

  Bendiske, Jennifer ^a   Caba, Ebru ^a   Brown, Queenie B ^a   Bahr, Ben A ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Acetylated tubulin; Alzheimer disease; Hippocampal slice culture; Neurodegeneration; Paired helical filaments; Tau

Indexed keywords

CHLOROQUINE;

ARTICLE; CELL DEATH; COGNITION; DENDRITE; HIPPOCAMPUS; HUMAN; MICROTUBULE; NERVE CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROCESSING; SYNAPSE; SYNAPTOGENESIS;

EID: 0036293375     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/61.7.640     Document Type: Article

References (71)

1. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
2. Huntingtin localization in brains of normal and Huntington's disease patients
3. Parkinsonism
4. Properties of the endosomal-lysosomal system in the human central nervous system: Disturbance mark most neurons in populations at risk to degenerate in Alzheimer's disease
5. Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy
6. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alteration of the ubiquitin-dependent degradation system, loss of dopamine release and autophagic cell death
7. The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects
8. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain
9. The lysosomal system in neurons. Involvement at multiple stages of Alzheimer's disease pathogenesis
10. Targeting of cell-surface beta-amyloid precursor protein to lysosomes: Alternative processing into amyloid-bearing fragments
11. Induction of β-amyloid-containing polypeptides in hippocampus: Evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin
12. Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein
13. Intracellular A beta 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells
14. Carboxyl-terminal fragments of Alzheimer beta-amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in presenilin 1-deficient cells
15. β-amyloid precursor protein fragments and lysosomal dense bodies are found in rat brain neurons after ventricular infusion of leupeptin
16. Protease inhibitors generate cytotoxic fragments from Alzheimer amyloid protein precursor in cDNA-transfected glioma cells
17. Processing of the beta-amyloid precursor. Multiple proteases generate and degrade potentially amyloidogenic fragments
18. Protease inhibition causes some manifestations of aging and Alzheimer's disease in rodent and primate brain
19. Routes of excretion of neuronal lysosomal dense bodies after ventricular infusion of leupeptin in the rat: A study using ubiquitin and PGP 9.5 immunocytochemistry
20. Long-term hippocampal slices: A model system for investigating synaptic mechanisms and pathologic processes
21. Cytoskeletal changes in rat cortical neurons induced by long-term intraventricular infusion of leupeptin
22. Lysosomal protease inhibitors induce meganeurites and tangle-like structures in entorhinohippocampal regions vulnerable to Alzheimer's disease
23. Neurofibrillary tangles of paired helical filaments
24. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease
25. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau
26. A68: A major subunit of paired helical filaments and derivatized forms of normal tau
27. Age-related phosphorylation and fragmentation events influence the distribution profiles of distinct tau isoforms in mouse brain
28. Hyman BT Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
29. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease
30. Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease
31. Synaptophysin gene expression in human brain: A quantitative in situ hybridization and immunocytochemical study
32. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease
33. Synaptic pathology of Alzheimer's disease
34. Hippocampal connectivity and Alzheimer's dementia: Effects of synapse loss and tangle frequency in a two-component model
35. Chloroquine inhibits intracellular degradation but not secretion of Alzheimer □/A4 amyloid precursor protein
36. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives
37. Protein degradation in cultured cells. II. The uptake of chloroquine by rat fibroblasts and the inhibition of cellular protein degradation and cathepsin B1
38. R antigen (GR53) in brain tissue
39. Specific proteolysis of the NR2 subunit at multiple sites by calpain
40. Changes in the concentrations of tau and other structural proteins in the brains of aged mice
41. Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins
42. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms
43. Dynamics of alpha-tubulin deacetylation in intact neurons
44. Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease
45. Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles
46. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia
47. Synapsin I (Protein I) in different brain regions in senile dementia of Alzheimer type and in multiinfarct dementia
48. Regional synaptic pathology in Alzheimer's disease
49. Synaptic pathology in Alzheimer's disease: Immunological data for markers of synaptic and large dense-core vesicles
50. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
51. Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele
52. Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzhemer's disease
53. Alz-50/Gallyas-positive lysosome-like intraneuronal granules in Alzheimer's disease and control brains
54. Chloroquine myopathy suggests that tau is degraded in lysosomes: Implication for the formation of paired helical filaments in Alzheimer's disease
55. Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHF-tau in Alzheimer's disease
56. Lysosomes as key organelles in the pathogenesis of prion encephalopathies
57. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents
58. Effects of inhibitors of protein degradation on the rate of protein synthesis in Chinese hamster ovary cells
59. Reduction of acetylated α-tubulin immuno-reactivity in neurofibrillary tangle-bearing neurons in Alzheimer's disease
60. Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis
61. Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice
62. Tauopathy in Drosophila: Neurodegeneration without neurofibrillary tangles
63. Axonal transport in neurological disease
64. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP
65. Tau domains, phosphorylation, and interactions with microtubules
66. Phenotypic down-regulation of glutamate receptor subunit GluR1 in Alzheimer's disease
67. Glutamate (NMDA) receptor NR1 subunit mRNA expression in Alzheimer's disease
68. The neuropathogenic contribution of lysosomal dysfunction
69. Peptidyl α-keto amide inhibitors of calpain block excitotoxic damage without affecting signal transduction events
70. Survival signaling and selective neuroprotection through glutamatergic transmission